These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 22319497)

  • 21. Functional characterization of NAD dependent de-acetylases SIRT1 and SIRT2 in B-Cell Chronic Lymphocytic Leukemia (CLL).
    Bhalla S; Gordon LI
    Cancer Biol Ther; 2016; 17(3):300-9. PubMed ID: 26794150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sirtuins (histone deacetylases III) in the cellular response to DNA damage--facts and hypotheses.
    Kruszewski M; Szumiel I
    DNA Repair (Amst); 2005 Nov; 4(11):1306-13. PubMed ID: 16084131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NAD(+), sirtuins, and cardiovascular disease.
    Borradaile NM; Pickering JG
    Curr Pharm Des; 2009; 15(1):110-7. PubMed ID: 19149606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sirtuin family in autoimmune diseases.
    Tao Z; Jin Z; Wu J; Cai G; Yu X
    Front Immunol; 2023; 14():1186231. PubMed ID: 37483618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammalian Sirtuins SIRT4 and SIRT7.
    Li S; Zheng W
    Prog Mol Biol Transl Sci; 2018; 154():147-168. PubMed ID: 29413176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Will Sirtuins Be Promising Therapeutic Targets for TBI and Associated Neurodegenerative Diseases?
    Yang Q; Zhou Y; Sun Y; Luo Y; Shen Y; Shao A
    Front Neurosci; 2020; 14():791. PubMed ID: 32848564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functions of mammalian SIRT4 in cellular metabolism and research progress in human cancer.
    Wang C; Liu Y; Zhu Y; Kong C
    Oncol Lett; 2020 Oct; 20(4):11. PubMed ID: 32774484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sirtuins and renal diseases: relationship with aging and diabetic nephropathy.
    Kitada M; Kume S; Takeda-Watanabe A; Kanasaki K; Koya D
    Clin Sci (Lond); 2013 Feb; 124(3):153-64. PubMed ID: 23075334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sirtuin inhibitors.
    Alcaín FJ; Villalba JM
    Expert Opin Ther Pat; 2009 Mar; 19(3):283-94. PubMed ID: 19441904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of altered sirtuins in metabolic regulation and oral cancer.
    Quan X; Xin Y; Wang HL; Sun Y; Chen C; Zhang J
    PeerJ; 2023; 11():e14752. PubMed ID: 36815979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial sirtuins.
    Huang JY; Hirschey MD; Shimazu T; Ho L; Verdin E
    Biochim Biophys Acta; 2010 Aug; 1804(8):1645-51. PubMed ID: 20060508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SIRT1 and SIRT6 Signaling Pathways in Cardiovascular Disease Protection.
    D'Onofrio N; Servillo L; Balestrieri ML
    Antioxid Redox Signal; 2018 Mar; 28(8):711-732. PubMed ID: 28661724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Pleiotropic Function of Human Sirtuins as Modulators of Metabolic Pathways and Viral Infections.
    Alqarni MH; Foudah AI; Muharram MM; Labrou NE
    Cells; 2021 Feb; 10(2):. PubMed ID: 33669990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promising drug discovery strategies for sirtuin modulators: what lessons have we learnt?
    Garg G; Singh AK; Singh S; Rizvi SI
    Expert Opin Drug Discov; 2021 Aug; 16(8):915-927. PubMed ID: 33880981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sirtuins: the future insight.
    Suvarna BS
    Kathmandu Univ Med J (KUMJ); 2012; 10(38):77-82. PubMed ID: 23132482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sirtuins: Possible Clinical Implications in Cardio and Cerebrovascular Diseases.
    Conti V; Forte M; Corbi G; Russomanno G; Formisano L; Landolfi A; Izzo V; Filippelli A; Vecchione C; Carrizzo A
    Curr Drug Targets; 2017; 18(4):473-484. PubMed ID: 26477463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases.
    Manjula R; Anuja K; Alcain FJ
    Front Pharmacol; 2020; 11():585821. PubMed ID: 33597872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diversity of histone versus nonhistone sirtuin substrates.
    Martínez-Redondo P; Vaquero A
    Genes Cancer; 2013 Mar; 4(3-4):148-63. PubMed ID: 24020006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sirtuin deacetylases in neurodegenerative diseases of aging.
    Herskovits AZ; Guarente L
    Cell Res; 2013 Jun; 23(6):746-58. PubMed ID: 23689277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two novel SIRT1 activators, SCIC2 and SCIC2.1, enhance SIRT1-mediated effects in stress response and senescence.
    Scisciola L; Sarno F; Carafa V; Cosconati S; Di Maro S; Ciuffreda L; De Angelis A; Stiuso P; Feoli A; Sbardella G; Altucci L; Nebbioso A
    Epigenetics; 2020; 15(6-7):664-683. PubMed ID: 31942817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.